Sepsis and Myocarditis

ConditionSepsis-related Myocarditis

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorJimma University

About this trial

This prospective cohort study aims to investigate the cardiac manifestations of sepsis and their influence on disease outcomes among adult patients at Jimma University Medical Center, Ethiopia, from May 2025 to May 2026. The research will include adults aged 18 and older with sepsis, categorizing them based on the presence or absence of cardiac involvement, which will be assessed through clinical symptoms, biomarkers, ECG, and echocardiographic findings. The study will evaluate the persistence of cardiac abnormalities, functional capacity, and survival over one year, utilizing structured data collection and advanced statistical methods, including survival analysis and regression techniques, to identify predictors of adverse outcomes.

Eligibility criteria

Qualifiers

All adult patients aged 18 years and above diagnosed with sepsis admitted to Jimma University Medical Center during the study periods that are willing to participate and continue follow-up of their disease condition for at least one year.

Disqualifiers

Patients with any kind of pre-existing established cardiac disease prior to their sepsis diagnosis and those who are not willing to participate or not willing to have follow-up of their disease condition for at least one year.

Trial design

Treatments tested in this trial

Standard treatment for sepsis of any focus
Treatment for the sepsis with standard management of cardiac failure

Treatment groups

226 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Jimma University

Lead sponsor

Ethiopian Society of Cardiac Professionals

Collaborator

Source ClinicalTrials.gov